Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
105M
-
Number of holders
-
636
-
Total 13F shares, excl. options
-
73.6M
-
Shares change
-
+1.1M
-
Total reported value, excl. options
-
$29.7B
-
Value change
-
+$468M
-
Put/Call ratio
-
1.27
-
Number of buys
-
290
-
Number of sells
-
-270
-
Price
-
$404.04
Significant Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q3 2018
734 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q3 2018.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 636 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 73.6M shares
of 105M outstanding shares and own 70.09% of the company stock.
Largest 10 shareholders include Capital World Investors (6.38M shares), BlackRock Inc. (5.86M shares), Vanguard Group Inc (5.75M shares), FMR LLC (5.02M shares), WELLINGTON MANAGEMENT GROUP LLP (4.08M shares), LOOMIS SAYLES & CO L P (3.35M shares), STATE STREET CORP (3.23M shares), HARRIS ASSOCIATES L P (3.17M shares), SANDS CAPITAL MANAGEMENT, LLC (2.18M shares), and Capital International Investors (1.74M shares).
This table shows the top 636 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.